The relative accuracy of blood glucose meters has of course been in the spotlight of late, since the FDA held a hearing to “crack down” on this issue last Fall. Funny, but I always assumed this had more to do with the technology inside the meter than the test strips themselves. Silly me.
One of this year’s buzzwords at the ADA Conference in Orlando last week was the “PQQ Enzyme” {glucose dehydrogenase (GDH)-pyrroloquino-linequinone (PQQ)} –…
Your questions answered… to the best of my abilities…
A bunch of you have been wondering if I’m a Mac or PC person. The answer is PC, by force. That is, I started out on the Mac many moons ago when I was working in magazine publishing in Germany; I loved the interface then as now. But soon I was back in the States, working in enterprise high-tech, which was all about the PCs, of…
Thankfully, many readers send me emails when they hear about something newsworthy/ different/ fun/ controversial/ or quirky in the world of diabetes. Thank you! And keep those tips coming, pahhhleeese, People.
Today, from the mailbag, three items that I simply had to share:
New OneTouch Delica Lancing Device
This one’s so new it doesn’t even appear on the JNJ OneTouch website yet — but appears to available via DiabeticPromotions.
According to my reader tip: “At first…
Robert Oringer is currently Co-Chairman and Board Director of AMG Medical Inc. in Canada, which distributes professional and home healthcare products. But he’s also the man who pioneered private-label diabetes products in the US, including syringes, glucose products, and testing supplies.
One might call Robert a serial diabetes entrepreneur — and at least as importantly, father of two teenage boys with type 1 diabetes. We catch up with him today in his role as a…
Read more »
At the end of last year (so, basically, two weeks ago), the Juvenile Diabetes Research Foundation announced a joint partnership with the Johnson & Johnson Corporate Office of Science and Technology to help with the discovery and development of drugs to promote beta cell survival. The program will look to fund research at academic centers around the world that could eventually lead to novel new drugs for the prevention and treatment of type 1 diabetes.
Sounds…